Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10

被引:0
|
作者
Saito, I
Haruta, K
Shimuta, M
Inoue, H
Sakurai, H
Yamada, K
Ishimaru, N
Higashiyama, H
Sumida, T
Ishida, H
Suda, T
Noda, T
Hayashi, Y
Tsubota, K
机构
[1] Univ Tokushima, Sch Dent, Dept Pathol, Tokushima 770, Japan
[2] Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan
[3] Kaneka Co, Res Inst, Takasago Res Labs, Takasago, Hyogo, Japan
[4] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 305, Japan
[5] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan
[6] Osaka Biosci Inst, Dept Mol Biol, Osaka, Japan
[7] Inst Canc, Dept Cell Biol, Toshima Ku, Tokyo, Japan
来源
JOURNAL OF IMMUNOLOGY | 1999年 / 162卷 / 05期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although IL-10 has been implicated in the pathogenesis of several autoimmune diseases, the mechanisms by which this cytokine mediates inflammatory lesions remain to be elucidated, Exocrine gland destruction is an important early step in the development of Sjogren's syndrome. To better understand the role of IL-10 in Sjogren's syndrome, we made transgenic mice in which the mouse IL-10 gene was regulated by the human salivary amylase promoter, Transgenic expression of IL-10 induced apoptosis of glandular tissue destruction and lymphocyte infiltration consisting primarily of Fas-ligand (FasL)(+) CD4(+) T cells, as well as in vitro upregulation of FasL expression on T cells, These data suggest that overexpression of IL-10 in the glands and their subsequent Fas/FasL-mediated bystander tissue destruction is a causal factor in the development of this disease.
引用
收藏
页码:2488 / 2494
页数:7
相关论文
共 50 条
  • [1] Detection of sialadenitis resembling Sjogren's syndrome exocrinopathy in B10.Q congenic mice.
    Skarstein, K
    Nakken, B
    Sundler, M
    Lindqvist, AK
    Holmdahl, R
    Jonsson, R
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S301 - S301
  • [2] FAS ligand-mediated liver disease in mice
    Bobé, P
    Bonardelle, D
    Grandjon, D
    Godeau, F
    Joulin, V
    Tricottet, V
    Reynès, M
    Kiger, N
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 1065 - 1071
  • [3] Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen-deficient mice of healthy background
    Ishimaru, N
    Arakaki, R
    Watanabe, M
    Kobayashi, M
    Miyazaki, K
    Hayashi, Y
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04): : 1481 - 1490
  • [4] EXOCRINOPATHY RESEMBLING SJOGRENS SYNDROME IN HTLV-1 TAX TRANSGENIC MICE
    GREEN, JE
    HINRICHS, SH
    VOGEL, J
    JAY, G
    NATURE, 1989, 341 (6237) : 72 - 74
  • [5] Salivary IL-10 in primary Sjogren's syndrome.
    Grisius, MM
    Fox, PC
    JOURNAL OF DENTAL RESEARCH, 1997, 76 : 688 - 688
  • [6] Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis
    Ishimaru, N
    Saegusa, K
    Yanagi, K
    Haneji, N
    Saito, I
    Hayashi, Y
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (01): : 173 - 181
  • [7] Observation of Sjogren's syndrome in IL-14α transgenic mice
    Xu, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S17 - S17
  • [8] IL-10 microsatellite polymorphisms in primary Sjogren's syndrome (pSS).
    Anaya, JM
    Eskdale, J
    Correa, PA
    Mantilla, RD
    Gallagher, G
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S137 - S137
  • [9] In vivo role of IL-10 and IL-12 during development of Sjogren's syndrome in MRL/lpr mice
    Yanagi, K
    Haneji, N
    Hamano, H
    Takahashi, M
    Higashiyama, H
    Hayashi, Y
    CELLULAR IMMUNOLOGY, 1996, 168 (02) : 243 - 250
  • [10] Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism
    Anaya, JM
    Correa, PA
    Herrera, M
    Eskdale, J
    Gallagher, G
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (09) : 1874 - 1876